MET Biotechnology

MET Biotechnology

by | Nov 8, 2025

MET Biotechnology develops technology platforms that enable multifunctional and programmable extracellular vesicle (EV)-based therapeutics. Market Opportunity: EVs are natural nanoscale carriers with potential for low immunogenicity, tissue targeting and engineered...
Mervyn’s Petcare, Inc.

Mervyn’s Petcare, Inc.

by | Jul 21, 2025

Mervyn’s Petcare, Inc. A cat-first health supplement company developing science-based, compliance-friendly products designed specifically for cats. Market: 42 million U.S. households have cats, yet fewer than 25% of pet supplements are designed specifically for...
Yuyu Bio, Inc.

Yuyu Bio, Inc.

by | Jul 21, 2025

A biotechnology company developing biologics for chronic, underserved conditions in pets. Market: Cats represent over 370 million pets globally. There are currently not many approved biologics for major feline conditions. Yuyu Bio aims to lead this untapped market by...
RiboForge

RiboForge

by | Jul 3, 2025

RiboForge is a biotech startup developing small molecule therapeutics targeting RNA structures. Market: The market for RNA-targeted small molecule drugs is substantial. Multiple indications in oncology, neurodegenerative disorders, and genetic disease involve a...
Purpose Bio

Purpose Bio

by | Jul 3, 2025

Over 1 billion patients with unmet needs in fatty liver, high cholesterol, and obesity—Purpose Bio delivers safe, oral enzyme therapies to transform care Market Opportunity: Over 1 billion people suffer from fatty liver, high cholesterol, obesity, and related...